Cargando…
MiR-140-3p is Involved in In-Stent Restenosis by Targeting C-Myb and BCL-2 in Peripheral Artery Disease
Aim: In-Stent Restenosis (ISR) is the major reason for recurrent ischemia and amputation after endovascular treatment of Peripheral Artery Disease (PAD). Our previous study demonstrated that miR-140-3p is significantly down-regulated in PAD arteries. However, expression and function of miR-140-3p in...
Autores principales: | Zhu, Zheng-Rong, He, Qiong, Wu, Wei-Bin, Chang, Guang-Qi, Yao, Chen, Zhao, Yang, Wang, Mian, Wang, Shen-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224204/ https://www.ncbi.nlm.nih.gov/pubmed/29760303 http://dx.doi.org/10.5551/jat.44024 |
Ejemplares similares
-
Roles of MicroRNAs in Peripheral Artery In-Stent Restenosis after Endovascular Treatment
por: Wang, Mo, et al.
Publicado: (2021) -
Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018) -
Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016) -
In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010) -
MiR-140 promotes the progression of intracranial aneurysms by targeting BCL2L2
por: Deng, Jun, et al.
Publicado: (2022)